Abstract:Background: The currently used conventional susceptibility testing for drug-resistant Mycobacterium tuberculosis (M.TB) is limited due to being time-consuming and having low efficiency. Herein, we propose the use of a microfluidic-based method to rapidly detect drug-resistant gene mutations using Kompetitive Allele-Specific PCR (KASP).Methods: A total of 300 clinical samples were collected, and DNA extraction was performed using the "isoChip & REG;" Mycobacterium detection kit. Phenotypic susceptibility testing and Sanger sequencing were performed to sequence the PCR products. Allele-specific primers targeting 37 gene mutation sites were designed, and a microfluidic chip (KASP) was constructed using 112 reaction chambers to simultaneously detect multiple mutations. Chip validation was performed using clinical samples.Results: Phenotypic susceptibility of clinical isolates revealed 38 rifampicin (RIF)-resistant, 64 isoniazid (INH)-resistant, 48 streptomycin (SM)-resistant and 23 ethambutol (EMB)-resistant strains, as well as 33 multi-drug-resistant TB (MDR-TB) strains and 20 strains fully resistant to all four drugs. Optimization of the chip-based detection system for drug resistance detection showed satisfactory specificity and maximum fluorescence at a DNA concentration of 1x101 copies/& mu;L. Further analysis revealed that 76.32% of the RIF-resistant strains harbored rpoB gene mutations (sensitivity, 76.32%; specificity 100%), 60.93% of the INH-resistant strains had katG gene mutations (sensitivity, 60.93%; specificity, 100%), 66.66% of the SM-resistant strains carried drug resistance gene mutations (sensitivity, 66.66%; specificity, 99.2%), and 69.56% of the EMB-resistant strains had embB gene mutations (sensitivity, 69.56%; specificity, 100%). Further, the overall agreement between the microfluidic chip and Sanger sequencing was satisfactory, with a turnaround time of the microfluidic chip was approximately 2 hours, much shorter than the conventional DST method.Conclusion: The proposed microfluidic-based KASP assay provides a cost-effective and convenient method for detecting mutations associated with drug resistance in M. tuberculosis. It represents a promising alternative to the traditional DST method, with satisfactory sensitivity and specificity and a much shorter turnaround time.

Mutation of Rifampicin-resistant Genes in M.tuberculosis with Gene Chip

Rapid Detection of Rpsl and Rrs Mutations in Mycobacterium Tuberculosis by DNA Chip

Identification of drug- resistant gene type in Mycobacterium tuberculosis by PCR- oligonucleotide microchips

Detection of Rifampicin-Resistance Mutations in Mycobacterium Tuberculosis

Rapid Detection of Rpob Gene Mutations in Rif-Resistant M. Tuberculosis Isolates by Oligonucleotide Microarray.

Establishment and Application of Multi-Pcr-sscp Assay for Rapid Detection of Isoniazid- and Rifampin-Resistance Mycobacterium Tuberculosis Isolates

[Detecting Rpob Gene Mutation in Rifampin-Resistant Mycobacterium Tuberculosis by Using the Reverse Dot-Blot Hybridization Method].

Rapid detection of mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis by oligonucleotide microarray

Study on Rpob Gene Mutations in Mycobacterium Tuberculosis

Molecular Detection of Multidrug Resistance and Characterizations of Mutations in Mycobacterium Tuberculosis Using Polycarbonate Track-Etched Membrane Based DNA Bio-Chip

Using Microfluidic Chip and Allele-Specific PCR to Rapidly Identify Drug Resistance-Associated Mutations of Mycobacterium tuberculosis

Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray: Detection of resistance genes in M. tuberculosis

Characterization and Rapid Detection of Mutations in RpoB Gene of Rifampin-Resistant Mycobacterium Tuberculosis Strains

Relativity of Rpob Gene Mutations in Mycobacterium Tuberculosis,Multi-drug Resistance and Degree of Resistance to Rifampin

Detection of Resistant Gene Mutations of Mycobacterium Tuberculosis in Sputum by PCR-membrane Chip

Characterization of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis from eastern China.

Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Mycobacterium tuberculosis Clinical Isolates Collected in Guangzhou Chest Hospital, China

Selection of Mutations to Detect Multidrug-Resistant Mycobacterium Tuberculosis Strains in Shanghai, China

PCR-membrane chip for detection of drug-resistant gene mutations of mycobacterium tuberculosis in paraffin-embedded tissues

Gene chip technology in the identi?cation and drug resistance of Mycobacterium

Molecular Mechanisms of Multiple Drug Resistance in Clinical Isolates of Mycobacterium tuberculosis